The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Novavax Inc., a biotechnology company developing next-generation vaccines for serious infectious diseases, announced data from the first co-...
read more
Jounce Therapeutics Inc., a clinical-stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers,...
read more
iTeos Therapeutics and GlaxoSmithKline plc agree to co-develop and co-commercialize EOS-448, an anti-TIGIT monoclonal antibody currently in phase I ...
read more
INOVIO, a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases, ...
read more
Regeneron Pharmaceuticals Inc. announced the U.S. FDA updated the Emergency Use Authorization (EUA) for REGEN-COV™, lowering the dose to 1,200 mg (600...
read more
Akoya Biosciences Inc. and The Spatial Biology Company® announced a collaboration with AstraZeneca to advance new multiplex immunofluorescence (mIF) ...
read more
Aeterna Zentaris Inc, a specialty biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic ...
read more
The U.S. Food and Drug Administration approved Tembexa (brincidofovir) to treat smallpox. Although the World Health Organization declared smallpox, a ...
read more
The PACIFIC Phase III trial showed AstraZeneca’s Imfinzi (durvalumab) demonstrated a sustained, clinically meaningful overall survival (OS) and ...
read more
VAXELIS™ (Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poliovirus, Haemophilus b Conjugate and Hepatitis B Vaccine), developed ...
read more
Paratek Pharmaceuticals Inc., a commercial-stage biopharmaceutical company focused on the development and commercialization of novel life-saving ...
read more
Akorn Operating Company, a leading specialty pharmaceutical company, announced that it has entered into a definitive agreement to sell its Consumer ...
read more
Biohaven Pharmaceutical Holding Company announced that the U.S. FDA has approved NURTEC® ODT (rimegepant 75 mg) for the preventive treatment of ...
read more
The U.S. FDA and the Federal Trade Commission issued warning letters to five companies for illegally selling dietary supplements that claim to cure, ...
read more
Humanigen, a clinical-stage biopharmaceutical company focused on preventing and treating an immune hyper-response called ‘cytokine storm’ with its ...
read more